TheJobsMapAbout K36 Therapeutics
K36 Therapeutics mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies.
Founded in 2021 by Yang Shi.
- Founded
- 2021
- Employees
- 1 to 10
- Total funding
- $100M
- Headquarters
- Cambridge
Leadership
The top of K36 Therapeutics's org chart, with how many people report into each leader.
TC
Terrence Connolly
President and Chief Executive Officer
8 reports
SC
Shinta Cheng
Chief Medical Officer
4 reports
HM
Heidi McIntyre
Director Clinical Operations
MB
Miriam Barnett
Director, Clinical Science
CL
Chad Lewis
Executive Director Of Technical Operations
Jobs at K36 Therapeutics
No open positions right now. Explore more companies on TheJobsMap.